Stocks and Investing
Stocks and Investing
Thu, July 27, 2023
[ Thu, Jul 27th 2023
] - WOPRAI
[ Thu, Jul 27th 2023
] - WOPRAI
[ Thu, Jul 27th 2023
] - WOPRAI
[ Thu, Jul 27th 2023
] - WOPRAI
[ Thu, Jul 27th 2023
] - WOPRAI
[ Thu, Jul 27th 2023
] - WOPRAI
[ Thu, Jul 27th 2023
] - WOPRAI
[ Thu, Jul 27th 2023
] - WOPRAI
Wed, July 26, 2023
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
[ Wed, Jul 26th 2023
] - WOPRAI
Mike Matson Maintained (ATRC) at Strong Buy with Increased Target to $68 on, Jul 26th, 2023
Mike Matson of Needham, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Increased Target from $60 to $68 on, Jul 26th, 2023.
Mike, nor any peers, have made any analyst calls on ATRC in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources